Trial intelligence / Profile preview

ISAR-TRIPLE: 6-week vs 6-month Clopidogrel

NCT00776633Phase 4Unknown

Sponsor
Deutsches Herzzentrum München
Start
Sep 2008
Primary completion
Dec 2013
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Deutsches Herzzentrum München. Status: unknown.

02

Drugs

clopidogrel
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00776633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00776633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call